Product image of Milgamma (Benfotiamine, Pyridoxine Hydrochloride) supplied by GNH India

Milgamma

Active Ingredient:
Benfotiamine, Pyridoxine Hydrochloride
Origin:
EU

Milgamma (Benfotiamine, Pyridoxine Hydrochloride)

Benfotiamine, the active ingredient in Milgamma, is a vitamin supplement presented as an oral formulation for supporting peripheral nerve health and managing symptoms of diabetic neuropathy. It works together with pyridoxine hydrochloride (vitamin B6) to address deficiencies of vitamins B1 and B6.

GNH India supplies Milgamma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance, and reliable supply chain management for healthcare providers.

Manufacturer / TM Owner

Wörwag Pharma Gmbh & Co. Kg

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Milgamma, a combined benfotiamine and pyridoxine supplement, is used to support nerve function and address vitamin B1/B6 deficiencies.

  • Peripheral nerve health: helps maintain nerve function and reduce discomfort in conditions affecting peripheral nerves.
  • Diabetic neuropathy: may alleviate symptoms such as tingling, burning, or pain associated with diabetic nerve damage.
  • Vitamin B1 and B6 deficiency: provides essential thiamine and pyridoxine to prevent or correct deficiencies.

How It Works

  • Benfotiamine is a lipid‑soluble thiamine pro‑drug that readily crosses cell membranes, where it is converted to active thiamine diphosphate, enhancing carbohydrate metabolism and reducing advanced glycation end‑product formation. Pyridoxine hydrochloride (vitamin B6) serves as a cofactor for enzymes in amino‑acid transamination, neurotransmitter synthesis, and glycogen breakdown, together supporting neuronal health and metabolic balance.

Side Effects

Milgamma may be associated with the following adverse reactions, which are generally mild and reversible.

Common Side Effects

  • Gastrointestinal discomfort: mild nausea, abdominal cramps, or dyspepsia.
  • Skin reactions: rash or pruritus at the site of exposure.
  • Headache: transient mild headache.

Serious or Rare Side Effects

  • Hypersensitivity: anaphylactic reaction, swelling of face or throat.
  • Hematologic changes: rare cases of leukopenia or thrombocytopenia.
  • Severe liver injury: extremely uncommon reports of hepatitis.

Precautions & Warnings

When using Milgamma, consider the following precautions.

  • Pregnancy: safety not established; use only if clearly needed.
  • Breastfeeding: insufficient data; evaluate risk versus benefit.
  • Renal impairment: monitor as vitamin B6 accumulation may occur.
  • Drug interactions: review concomitant medications that affect vitamin metabolism.
  • Underlying conditions: assess for existing neuropathy causes before use.
  • Store at ambient temperature: keep below 25 °C, retain original packaging, protect from moisture and light.

Avoid Interactions

Milgamma can interact with other medicines; monitor accordingly.

Major Interactions (Avoid)

  • Anticonvulsants (e.g., phenobarbital): may increase vitamin B6 metabolism, reducing efficacy.
  • High‑dose pyridoxine: can cause sensory neuropathy; avoid concurrent high supplemental doses.

Moderate Interactions (Monitor Closely)

  • Chemotherapy agents (e.g., cisplatin): may potentiate neurotoxicity; monitor nerve function.
  • Oral contraceptives: possible alteration in vitamin metabolism; observe for side effects.
  • Alcohol: excessive intake can impair thiamine utilization; advise moderation.

Frequently Asked Questions

Milgamma is a combined benfotiamine and pyridoxine (vitamin B6) supplement used to support peripheral nerve health, help manage symptoms of diabetic neuropathy, and prevent or correct deficiencies of vitamins B1 (thiamine) and B6.

Benfotiamine is a lipid‑soluble pro‑drug of thiamine that easily enters cells and is converted to active thiamine diphosphate. This boosts carbohydrate metabolism, reduces harmful advanced glycation end‑products, and supports neuronal function, especially in the presence of high glucose levels.

The appropriate dose of Milgamma is determined by the prescribing healthcare professional based on the individual’s clinical condition, age, and other factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for Milgamma in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made together with a qualified healthcare provider.

To order Milgamma, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Milgamma combines benfotiamine, a highly bioavailable thiamine pro‑drug, with pyridoxine, offering potentially greater cellular uptake than standard thiamine or pyridoxine tablets. This may translate into more effective support of nerve metabolism, though clinical outcomes depend on individual patient factors.

Milgamma should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture and direct sunlight, and ensure the packaging remains sealed until use.

Milgamma is taken orally, usually with a glass of water. It can be taken with or without food, but following the prescriber’s guidance on timing relative to meals is recommended for optimal absorption.

Serious risks, though rare, include hypersensitivity reactions such as anaphylaxis, severe skin eruptions, and hematologic abnormalities like leukopenia or thrombocytopenia. Patients should seek immediate medical attention if they experience swelling, difficulty breathing, or unexplained bruising.

Milgamma should be avoided in individuals with known hypersensitivity to benfotiamine, pyridoxine, or any excipients in the formulation. It is also contraindicated in patients with severe renal impairment unless closely monitored, and it should not be used without medical advice during pregnancy or lactation.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Benfotiamine, Pyridoxine Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT